Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Updates on triple-negative breast cancer and immunotherapy

Dr Avan Armaghani - Moffitt Cancer Center, Tampa, USA
Updates on triple-negative breast cancer and immunotherapy ( Dr Avan Armaghani -  Moffitt Cancer Center, Tampa, USA )
7 Jul 2023

Liquid biopsies and cancer: The role of NGS, CTC, exosomes, cfDNA and cfRNA

Dr Bruna Pellini - Moffitt Cancer Center, Tampa, USA
Liquid biopsies and cancer: The role of NGS, CTC, exosomes, cfDNA and cfRNA ( Dr Bruna Pellini - Moffitt Cancer Center, Tampa, USA )
7 Jul 2023

Predictive and prognostic biomarkers for immunotherapy in lung cancer

Dr Ignacio Gil Bazo - Fundación Instituto Valenciano de Oncología (FIVO), Valencia, Spain
Predictive and prognostic biomarkers for immunotherapy in lung cancer ( Dr Ignacio Gil Bazo - Fundación Instituto Valenciano de Oncología (FIVO), Valencia, Spain )
7 Jul 2023

Gynaecological cancer: New targets and immunotherapy developments

Dr Mark Shahin - Jefferson Health, Philadelphia, USA
Gynaecological cancer: New targets and immunotherapy developments ( Dr Mark Shahin - Jefferson Health, Philadelphia, USA )
7 Jul 2023

Molecular oncology and translational medicine

Dr Gregg Fields - Florida Atlantic University, Florida, USA
Molecular oncology and translational medicine ( Dr Gregg Fields - Florida Atlantic University, Florida, USA )
7 Jul 2023

Adjuvant nivolumab vs placebo in resected oesophageal or gastroesophageal junction cancer following chemo: Biomarker analysis

Dr Ronan Kelly - Baylor University Medical Center, Texas, USA
Adjuvant nivolumab vs placebo in resected oesophageal or gastroesophageal junction cancer following chemo: Biomarker analysis ( Dr Ronan Kelly - Baylor University Medical Center, Texas, USA )
7 Jul 2023

Potential benefit to response rates from trastuzumab added to perioperative chemotherapy for patients with HER-2+ GC

Dr Anna Wagner - The University of Lausanne, Lausanne, Switzerland, Co-chair of the EORTC Gastric Cancer Task Force
Potential benefit to response rates from trastuzumab added to perioperative chemotherapy for patients with HER-2+ GC ( Dr Anna Wagner - The University of Lausanne, Lausanne, Switzerland, Co-chair of the EORTC Gastric Cancer Task Force )
6 Jul 2023

Lenvatinib plus pembrolizumab versus standard of care for previously treated metastatic colorectal cancer

Dr Akihito Kawazoe - National Cancer Center Hospital East, Kashiwa, Japan
Lenvatinib plus pembrolizumab versus standard of care for previously treated metastatic colorectal cancer ( Dr Akihito Kawazoe - National Cancer Center Hospital East, Kashiwa, Japan )
6 Jul 2023

Botensilimab plus balstilimab for metastatic heavily pretreated microsatellite stable colorectal cancer

Dr Andrea Bullock - Beth Israel Deaconess Medical Center, Boston, USA
Botensilimab plus balstilimab for metastatic heavily pretreated microsatellite stable colorectal cancer ( Dr Andrea Bullock - Beth Israel Deaconess Medical Center, Boston, USA )
5 Jul 2023

Whole exome sequencing reveals genomic landscape of appendiceal adenocarcinoma

Dr Michael White - MD Anderson Cancer Center, Houston, USA
Whole exome sequencing reveals genomic landscape of appendiceal adenocarcinoma ( Dr Michael White - MD Anderson Cancer Center, Houston, USA )
5 Jul 2023

The role of the workforce in implementing Choosing Wisely in cancer care

Dr Nazik Hammad - Cancer Centre of Southeastern Ontario, Kingston, Canada
The role of the workforce in implementing Choosing Wisely in cancer care ( Dr Nazik Hammad - Cancer Centre of Southeastern Ontario, Kingston, Canada )
29 Jun 2023

The role of provider assumptions in decreasing access to care in the LGBTQ community

Dr Narjust Flores - Dana-Farber Cancer Institute, Boston, USA
The role of provider assumptions in decreasing access to care in the LGBTQ community ( Dr Narjust Flores - Dana-Farber Cancer Institute, Boston, USA )
28 Jun 2023